Medlex Biotechnics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 4 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 17-11-2024
- Revenue -19.12%
(FY 2023)
- Profit -28.53%
(FY 2023)
- Ebitda -35.34%
(FY 2023)
- Net Worth 74.89%
(FY 2023)
- Total Assets 11.59%
(FY 2023)
About Medlex Biotechnics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Satwant Singh and Ajay serve as directors at the Company.
- CIN/LLPIN
U24290CH2020PTC043399
- Company No.
043399
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Medlex Biotechnics Private Limited offer?
Medlex Biotechnics Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, PCD Pharma Franchise, Cardiovascular Drugs & Medication, Cholesterol Medicine, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Antibacterial Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines.
Who are the key members and board of directors at Medlex Biotechnics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satwant Singh  | Director | 16-Dec-2020 | Current |
| Ajay | Director | 16-Dec-2020 | Current |
Financial Performance of Medlex Biotechnics.
Medlex Biotechnics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.12% decrease. The company also saw a substantial fall in profitability, with a 28.53% decrease in profit. The company's net worth Soared by an impressive increase of 74.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medlex Biotechnics?
Unlock access to Medlex Biotechnics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Grapple Lifesciences Private LimitedActive 13 years 1 monthSatwant Singh and Ajay are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Jul 2024 | ₹5.00 M | Open |
How Many Employees Work at Medlex Biotechnics?
Medlex Biotechnics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medlex Biotechnics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medlex Biotechnics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
